Rhythm Pharmaceuticals, Inc. RYTM Cash Flow Statement
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| -$202.68M-20.1% | -$196.54M+24.6% | -$192.33M+25.7% | -$183.1M+29.4% | -$168.73M+38.4% | ||
| $77.06M+72.1% | $66.82M+68.4% | $58.11M+53.7% | $50.3M+42.0% | $44.78M+31.9% | ||
| —— | —— | —— | —— | —— | ||
| $10.46M-3.2% | $7.95M-21.4% | $7.87M+28.4% | $7.32M+25.9% | $10.81M+258% | ||
| $19.91M+1.9% | $21.89M-0.1% | $35.82M+209% | $32.31M+295% | $19.54M+134% | ||
| $64K+101% | $397K+105% | -$5.07M-60.6% | -$11.22M-303% | -$6.85M-132% | ||
| —— | —— | —— | —— | $0— | ||
| —— | —— | —— | —— | -$1.29M— | ||
| -$119.51M-5.3% | -$115.68M-1.6% | -$109.13M+12.3% | -$107.72M+16.1% | -$113.49M+19.2% | ||
| $357.35M— | $348.67M— | $394.7M— | $262.48M— | —— | ||
| $293.39M+17.9% | $252.47M-3.1% | $288.36M+22.0% | $272.16M+2.5% | $248.92M-25.1% | ||
| —— | —— | —— | —— | —— | ||
| $19.59M+33.0% | $19.92M+54.4% | $18.33M+57.1% | $16.09M+53.3% | $14.73M+66.8% | ||
| —— | —— | —— | —— | $66.83M+22.2% | ||
| —— | —— | —— | —— | —— | ||
| —— | —— | —— | —— | $219.5M+179% | ||
| $537K+656% | $87K+4,250% | $1M+186% | $93K+119% | $71K+124% | ||
| -$45.9M-187% | -$36.85M-226% | $4.77M+128% | -$26.02M-156% | $52.67M+185% | ||
| $431K+8.0% | $428K+7.0% | $430K+8.6% | $434K+11.3% | $399K-4.5% | ||
| $1.21M-21.7% | $1.34M-14.4% | $1.45M-9.3% | $1.53M-7.5% | $1.54M-9.7% | ||
| —— | —— | —— | —— | —— | ||
| —— | —— | —— | —— | -$1.29M— | ||
| -$660K+22.4% | -$910K+35.9% | -$900K+32.8% | -$1.05M-9.4% | -$850K— | ||
| —— | —— | —— | $15.82M+1,074% | $6.31M— | ||
| -$6.17M+28.2% | -$6.52M+20.2% | -$6.8M— | -$7.57M— | -$8.58M— | ||
| $19.75M-10.2% | $20.58M-0.1% | $21.42M+11.7% | $21.92M+28.3% | $22M— | ||
| —— | —— | —— | —— | $0— | ||
| $357.35M— | $348.67M— | $394.7M— | $262.48M— | —— | ||
| $293.39M+17.9% | $252.47M-3.1% | $288.36M+22.0% | $272.16M+2.5% | $248.92M-25.1% | ||
| —— | $188.66M— | $141.49M— | $94.33M— | $47.16M— | ||
| $1.98M— | $1.58M— | —— | —— | —— | ||
| $537K+656% | $87K+4,250% | $1M+186% | $93K+119% | $71K+124% | ||
| —— | $0-100% | $4.68M-66.7% | $9.36M0.0% | $14.04M+200% | ||
| $5.16M-2.5% | $5.38M+35.5% | $5.39M+105% | $5.34M+310% | $5.29M— |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does Rhythm Pharmaceuticals, Inc. generate?
- Rhythm Pharmaceuticals, Inc. (RYTM) generated -$119.5M in operating cash flow over the trailing twelve months.
- Where does Rhythm Pharmaceuticals, Inc.'s cash flow data come from?
- Every line is extracted from Rhythm Pharmaceuticals, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
